Soliqua (lixisenatide/insulin glargine)

pCPA File Number: 21088
Negotiation Status:
Concluded with an LOI
Indication(s):
Diabetes Mellitus, Type 2
Sponsor/Manufacturer:
Sanofi-Aventis Canada Inc.
CDA-AMC Project Number:
SR0564-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: